Abstract
We evaluated the use of a new, controlled-release capsule form of carbamazepine, Carbatrol capsules, in an open-label, multicenter study of 124 patients with complex partial seizures. Ninety-one percent of the patients successfully completed the 6-month trial with good seizure control, with a significant improvement in quality of life. We conclude that switching patients with complex partial seizures from multiple daily-dose carbamazepine to twice-daily Carbatrol on a milligram-to-milligram basis is relatively safe.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1727-1729 |
| Number of pages | 3 |
| Journal | Neurology |
| Volume | 51 |
| Issue number | 6 |
| State | Published - 1998 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Neuroscience(all)
Cite this
Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures. / Mirza, W. U.; Rak, I. W.; Thadani, V. M.; Cereghino, James; Garnett, W. R.; Brown, L. M.; Zhang, Y.; Belendiuk, G. W.
In: Neurology, Vol. 51, No. 6, 1998, p. 1727-1729.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures
AU - Mirza, W. U.
AU - Rak, I. W.
AU - Thadani, V. M.
AU - Cereghino, James
AU - Garnett, W. R.
AU - Brown, L. M.
AU - Zhang, Y.
AU - Belendiuk, G. W.
PY - 1998
Y1 - 1998
N2 - We evaluated the use of a new, controlled-release capsule form of carbamazepine, Carbatrol capsules, in an open-label, multicenter study of 124 patients with complex partial seizures. Ninety-one percent of the patients successfully completed the 6-month trial with good seizure control, with a significant improvement in quality of life. We conclude that switching patients with complex partial seizures from multiple daily-dose carbamazepine to twice-daily Carbatrol on a milligram-to-milligram basis is relatively safe.
AB - We evaluated the use of a new, controlled-release capsule form of carbamazepine, Carbatrol capsules, in an open-label, multicenter study of 124 patients with complex partial seizures. Ninety-one percent of the patients successfully completed the 6-month trial with good seizure control, with a significant improvement in quality of life. We conclude that switching patients with complex partial seizures from multiple daily-dose carbamazepine to twice-daily Carbatrol on a milligram-to-milligram basis is relatively safe.
UR - http://www.scopus.com/inward/record.url?scp=0031700770&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031700770&partnerID=8YFLogxK
M3 - Article
C2 - 9855533
AN - SCOPUS:0031700770
VL - 51
SP - 1727
EP - 1729
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 6
ER -